Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

ATXN2 polyQ intermediate repeats are a modifier of ALS survival.

Chiò A, Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Restagno G, Conte A, Bisogni G, Marangi G, Moncada A, Lattante S, Zollino M, Sabatelli M, Bagarotti A, Corrado L, Mora G, Bersano E, Mazzini L, D'Alfonso S; PARALS..

Neurology. 2015 Jan 20;84(3):251-8. doi: 10.1212/WNL.0000000000001159. Epub 2014 Dec 19.

PMID:
25527265
2.

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

Chiò A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M, De Mercanti S, Bersano E, Cammarosano S, Ilardi A, Manera U, Moglia C, Sideri R, Marinou K, Bottacchi E, Pisano F, Cantello R, Mazzini L, Mora G; Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis..

JAMA Neurol. 2014 Sep;71(9):1134-42. doi: 10.1001/jamaneurol.2014.1129.

PMID:
25048026
3.

Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study.

Chiò A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, Mora G; PARALS..

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):377-81. doi: 10.1136/jnnp-2011-300472. Epub 2011 Oct 19.

PMID:
22013242
4.

ALS clinical trials: do enrolled patients accurately represent the ALS population?

Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, Calvo A, Mora G; PARALS group..

Neurology. 2011 Oct 11;77(15):1432-7. doi: 10.1212/WNL.0b013e318232ab9b. Epub 2011 Sep 28.

PMID:
21956723

Supplemental Content

Loading ...
Support Center